Robert L. Little
2006
In 2006, Robert L. Little earned a total compensation of $195.6K as Vice President and Chief Commercial Officer at Halozyme Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $21,750 |
|---|---|
| Option Awards | $29,608 |
| Salary | $144,141 |
| Other | $120 |
| Total | $195,619 |
Little received $144.1K in salary, accounting for 74% of the total pay in 2006.
Little also received $21.8K in non-equity incentive plan, $29.6K in option awards and $120 in other compensation.
Rankings
In 2006, Robert L. Little's compensation ranked 6,468th out of 7,022 executives tracked by ExecPay. In other words, Little earned more than 7.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,468 out of 7,022 | 8th |
Division Manufacturing | 2,248 out of 2,413 | 7th |
Major group Chemicals And Allied Products | 621 out of 673 | 8th |
Industry group Drugs | 469 out of 518 | 10th |
Industry Biological Products, Except Diagnostic Substances | 105 out of 112 | 6th |
Source: SEC filing on April 2, 2009.
Little's colleagues
We found five more compensation records of executives who worked with Robert L. Little at Halozyme Therapeutics in 2006.
2006
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2006
Gregory Frost
Halozyme Therapeutics
Chief Scientific Officer
2006
Richard Yocum
Halozyme Therapeutics
Vice President — Clinical Development and Medical Affairs
2006
David Ramsay
Halozyme Therapeutics
Chief Financial Officer
2006
William Fallon
Halozyme Therapeutics